Effect of excess levels of methionine, tryptophan, arginine, lysine or threonine on growth and dietary choice in the pig

Protein Ingredient Quality within Infant Formulas Impacts Plasma Amino Acid Concentrations in Neonatal Minipiglets

BACKGROUND

Infant formulas (IFs), the only adequate substitute to human milk, are complex matrices that require numerous ingredients and processing steps that may impact protein digestion and subsequent amino acid (AA) absorption.

OBJECTIVES

The objective was to understand the impact of the protein ingredient quality within IFs on postprandial plasma AA profiles.

METHODS

Four isonitrogenous and isocaloric IFs were produced at a semi-industrial scale using whey proteins from different origins (cheese compared with ideal whey) and denaturation levels (IF-A, -B, -C), and caseins with different supramolecular organizations (IF-C, -D). Ten Yucatan minipiglets (12- to 27-d-old) were used as a human infant model and received each IF for 3 d according to a Williams Latin square followed by a 2-d wash-out period. Jugular plasma was regularly sampled from 10 min preprandial to 4 h postprandial on the third day to measure free AAs, urea, insulin, and glucose concentrations. Data were statistically analyzed using a mixed linear model with diet (IFs), time, and sex as fixed factors and piglet as random factor.

RESULTS

IFs made with cheese whey (IF-A and -B) elicited significantly higher plasma total and essential AA concentrations than IFs made with ideal whey (IF-C and -D), regardless of the pre- and postprandial times. Most of the differences observed postprandially were explained by AA homeostasis modifications. IFs based on cheese whey induced an increased plasma concentration of Thr due to both a higher Thr content in these IFs and a Thr-limiting degrading capability in piglets. The use of a nonmicellar casein ingredient led to reduced plasma content of AA catabolism markers (IF-D compared with IF-C).

CONCLUSIONS

Overall, our results highlight the importance of the protein ingredient quality (composition and structure) within IFs on neonatal plasma AA profiles, which may further impact infant protein metabolism.

An oral gavage of lysine elicited early satiation while gavages of lysine, leucine, or isoleucine prolonged satiety in pigs

Excess dietary amino acids (AA) may negatively affect feed intake in pigs. Previous results showed that Lys, Leu, Ile, Phe, and Glu significantly increased gut peptide secretion (i.e., cholecystokinin, glucagon-like peptide 1). However, the link between dietary AA and gut peptide secretion with changes in feeding behavior patterns has not been demonstrated to date in pigs. The aim of the present study was to determine the effect of Lys, Leu, Ile, Phe, and Glu, on feed intake and meal patterns in young pigs. Twelve male pigs (Landrace × Large White, body weight = 16.10 ± 2.69 kg) were administered an oral gavage of water (control) or Lys, Leu, Ile, Phe, Glu, or glucose (positive control) at 3 mmol.kg-1 following an overnight fasting. The experiment consisted in measuring individual feed disappearance and changes in meal pattern (including latency to first meal, first meal duration, intermeal interval, second meal duration, and number of meals) based on video footage. Compared to the control group Lys significantly (P ≤ 0.01) reduced feed intake during the first 30 min and up to 2.5 h post-gavage, including a reduction (P ≤ 0.05) in the first meal duration. Similarly, Leu and Ile also significantly decreased feed intake up to 3 h post-gavage on a cumulative count. However, the strongest (P ≤ 0.01) impacts on feed intake by the two branched chained AA were observed after the first- or second-hour post-gavage for Leu or Ile, respectively. In addition, Leu or Ile did not affect the first meal duration (P ≥ 0.05). Leu significantly increased (P ≤ 0.01) the intermeal interval while decreasing (P ≤ 0.05) the number of meals during the initial 2 h following the gavage when compared with the control group. In contrast, the oral gavages of Phe or Glu had no significant impact (P > 0.05) on the feeding behavior parameters measured relative to the control pigs. In turn, glucose had a short-lived effect on appetite by reducing (P < 0.05) feed intake for 30 min after the first-hour post-gavage. In conclusion, the impact of an oral gavage of Lys on feeding behavior is compatible with a stimulation of early satiation and an increased duration of satiety. The main impact of the oral gavages of Leu and Ile was an increase in the duration of satiety. The gastrointestinal mechanisms associated with non-bound dietary AA sensing and the impact on voluntary feed intake warrant further investigations.

CCK and GLP-1 release in response to proteinogenic amino acids using a small intestine ex vivo model in pigs

The impact of individual amino acids (AA) on gut hormone secretion and appetite regulation in pigs remains largely unknown. The aim of the present study was to determine the effect of the 20 proteinogenic AA on the release of the anorexigenic hormones cholecystokinin (CCK) and glucagon-like peptide 1 (GLP-1) in postweaning pigs. Six 25-d-old male piglets (Domestic Landrace × Large White; body weight = 6.94 ± 0.29 kg) were humanely killed for the collection of intestinal segments from the duodenum, jejunum, and ileum. Tissue samples from the three intestinal segments were used to determine which of the regions were more relevant for the analysis of gut peptides. Only the segments with the highest CCK and GLP-1 secretion and expression levels were evaluated with the 20 individual AA. Tissue segments were cut open, cleaned, and stripped of their muscle layer before identical circular samples were collected and incubated in 24-well plates for 1 h (37 °C, 5% v/v CO₂). The culture broth consisted of a glucose-free KRB buffer containing no added AA (control) or with the addition of 10 mM of 1 of the 20 proteinogenic AA. Following incubation, tissues and supernatant were collected for gene expression and secretion analysis of CCK and GLP-1 levels. CCK secretion and mRNA expression were higher (P < 0.05) in duodenum when compared with proximal jejunum or ileum, whereas GLP-1/proglucagon levels were higher in ileum vs. duodenum (P < 0.05) and jejunum (P < 0.05, for GLP-1 only) in postweaning pigs. Based on these results, the effect of AA on CCK and GLP-1 secretion was studied in the duodenum and ileum, respectively. None of the AA tested stimulated both anorexigenic hormones. Of all the essential AA, Ile, Leu, Met, and Trp significantly (P < 0.05) stimulated GLP-1 from the ileum, while only Phe stimulated CCK from the duodenum. Of the nonessential AA, amide AA (Gln and Asn) caused the release of CCK, while Glu and Arg increased the release of GLP-1 from the ileum. Interpreting the results in the context of the digestion and absorption dynamics, non-bound AA are quickly absorbed and have their effect on gut peptide secretion limited to the proximal small intestine (i.e., duodenum), thus, mainly CCK. In contrast, protein-bound AA would only stimulate CCK release from the duodenum through feedback mechanisms (such as through GLP-1 secreted mainly in the ileum).

Amino Acids in Swine Nutrition and Production

Amino acids are the building blocks of proteins in animals, including swine. With the development of new analytical methods and biochemical research, there is a growing interest in fundamental and applied studies to reexamine the roles and usage of amino acids (AAs) in swine production. In animal nutrition, AAs have been traditionally classified as nutritionally essential (EAAs) or nutritionally nonessential (NEAAs). AAs that are not synthesized de novo must be provided in diets. However, NEAAs synthesized by cells of animals are more abundant than EAAs in the body, but are not synthesized de novo in sufficient amounts for the maximal productivity or optimal health (including resistance to infectious diseases) of swine. This underscores the conceptual limitations of NEAAs in swine protein nutrition. Notably, the National Research Council (NRC 2012) has recognized both arginine and glutamine as conditionally essential AAs for pigs to improve their growth, development, reproduction, and lactation. Results of recent work have also provided compelling evidence for the nutritional essentiality of glutamate, glycine, and proline for young pigs. The inclusion of so-called NEAAs in diets can help balance AAs in diets, reduce the dietary levels of EAAs, and protect the small intestine from oxidative stress, while enhancing the growth performance, feed efficiency, and health of pigs. Thus, both EAAs and NEAAs are needed in diets to meet the requirements of pigs. This notion represents a new paradigm shift in our understanding of swine protein nutrition and is transforming pork production worldwide.

Isolation of a Highly Efficient Antigenic-Protein-Degrading Bacillus amyloliquefaciens and Assessment of Its Safety

Simple Summary

Soybean meal (SBM), a byproduct of soybean oil extraction, is a commonly used dietary protein in the poultry and swine feed industries because of its high quality protein and relatively well-balanced amino acids. However, major antigenic proteins in SBM, glycinin and β-conglycinin, can trigger allergic reactions, including intestine villus atrophy and other malabsorption syndromes, in newborn animals. Microbial fermentation is considered an economically viable processing technique to reduce the content of antigenic proteins, and improve the nutritional quality of SBM. The kind of microorganism used in fermentation is one of the major factors affecting the nutritional value of SBM. In this study, a highly efficient Bacillus. amyloliquefaciens strain was successfully isolated with convenient and effective plate tests, and used in a fermentation experiment. Fermentation with B. amyloliquefaciens for 24 h effectively degraded the glycinin and β-conglycinin in SBM, significantly improved the crude protein content and acid soluble protein concentration, and increased the total amino acid content. Furthermore, B. amyloliquefaciens had no adverse effects on animal health. These results indicate that the B. amyloliquefaciens strain isolated in this study is safe for animal use and can be widely used in SBM fermentation.

Abstract

The aims of this study were to screen and isolate a highly efficient strain from the rumen of a cow that can degrade the antigenic soy proteins in soybean meal (SBM) and improve the nutritional value of SBM by fermenting it with this strain. The safety of this strain was investigated with an acute oral toxicity test. A Bacillus amyloliquefaciens strain was successfully screened with plate tests and fermentation. After solid state fermentation of SBM with B. amyloliquefaciens for 24 h, the amounts of glycinin and β-conglycinin, two major antigenic proteins in SBM, decreased by 92.32% and 85.05%, respectively. The crude protein content in the fermented soybean meal (FSBM) increased by 17.54% compared with that in SBM. Notably, the trichloroacetic-acid-soluble protein (TCA-SP) content, particularly small peptides and free amino acids, was 9.97-fold higher in FSBM than in SBM. The in vitro dry matter digestibility and digestible energy of SBM increased from 62.91% to 72.52% and from 10.42 MJ/kg to 13.37 MJ/kg (dry matter basis), respectively, after fermentation. The acute oral toxicity test suggested that the strain exerted no harmful effects on the relative organ weights, the morphological tissue structure, or the health of mice. These results indicate that the B. amyloliquefaciens strain isolated in this study is a safe strain for animals, and could be used to improve the nutritional quality of SBM by solid-state fermentation.

Meta-regression analysis to predict the influence of branched-chain and large neutral amino acids on growth performance of pigs1

A meta-analysis was conducted to evaluate the effects of branched-chain amino acids (BCAA), their interactions, and interactions with large neutral amino acids (LNAA) to develop prediction equations for growth performance of pigs. Data from 25 papers, published from 1995 to 2018, for a total of 44 trials and 210 observations were recorded in a database. Diets were reformulated using the NRC (2012) loading values to estimate nutrient concentrations. The response variables were average daily gain (ADG), average daily feed intake (ADFI), and gain-to-feed ratio (G:F). The predictor variables tested included average body weight (BW), crude protein, neutral detergent fiber, Ile:Lys, Leu:Lys, Val:Lys, BCAA:Lys, Ile:Leu, Val:Leu, Ile:Val, (Ile+Val):Leu, Trp:Lys, Leu:Trp, Ile:Trp, Val:Trp, BCAA:Trp, Met:Lys, Leu:Met, Ile:Met, Val:Met, BCAA:Met, His:Lys, Leu:His, Ile:His, Val:His, BCAA:His, Thr:Lys, Leu:Thr, Ile:Thr, Val:Thr, BCAA:Thr, (Phe+Tyr):Lys, Leu:(Phe+Tyr), Ile:(Phe+Tyr), Val:(Phe+Tyr), BCAA:(Phe+Tyr), LNAA:Lys, Leu:LNAA, Ile:LNAA, Val:LNAA, and BCAA:LNAA. Amino acids were expressed on standardized ileal digestible basis. The MIXED procedure of SAS (SAS Institute Inc., Cary, NC) was used to develop the equations. The inverse of squared SEM was used to account for heterogeneous errors using the WEIGHT statement. Models were selected with a step-wise manual forward selection. In order to be included in the final model, predictor variables had to be statistically significant (P < 0.05) and provide an improvement of at least 2 points in Bayesian information criterion. The optimum equations were: ADG, g = - 985.94 + (15.2499 × average BW (kg)) - (0.08885 × average BW × average BW) + (1.063 × Leu:Lys) + (20.2659 × Ile:Lys) - (0.1479 × Ile:Lys × Ile:Lys) + (9.2243 × (Ile+Val):Leu) - (0.03321 × (Ile+Val):Leu × (Ile+Val):Leu) - (0.4413 × Ile:Trp); G:F, g/kg = 648.3 - (6.2974 × average BW (kg)) + (0.02051 × average BW × average BW) + (0.5396 × Ile:Lys) + (1.7284 × Val:Lys) - (0.00795 × Val:Lys × Val:Lys) - (1.7594 × Met:Lys); and ADFI, kg = predicted ADG/predicted G:F. Overall, the prediction equations suggest that increasing Leu:Lys negatively impacts ADG due to a reduction in G:F and ADFI caused by insufficient levels of other BCAA and LNAA relative to Leu. According to the model, the addition of Val, Ile, and Trp, alone or in combination, has the potential to counteract the negative effects of high dietary Leu concentrations on growth performance.

BOARD-INVITED REVIEW: Arginine nutrition and metabolism in growing, gestating, and lactating swine

Arginine (Arg) has traditionally not been considered as a deficient nutrient in diets for gestating or lactating swine due to the assumption that these animals can synthesize sufficient amounts of Arg to meet their physiological needs. The lack of full knowledge about Arg nutrition has contributed to suboptimal efficiency of pork production. Over the past 25 yr, there has been growing interest in Arg metabolism in the pig, which is an agriculturally important species and a useful model for studying human biology. Arginine is a highly abundant amino acid in tissues of pigs, a major amino acid in allantoic fluid, and a key regulator of gene expression, cell signaling, and antioxidative reactions. Emerging evidence suggests that dietary supplementation with 0.5% to 1% Arg maintains gut health and prevents intestinal dysfunction in weanling piglets, while enhancing their growth performance and survival. Also, the inclusion of 1% Arg in diets is required to maximize skeletal muscle accretion and feed efficiency in growing pigs, whereas dietary supplementation with 1% Arg reduces muscle loss in endotoxin-challenged pigs. Furthermore, supplementing 0.83% Arg to corn- and soybean meal-based diets promotes embryonic/fetal survival in swine and milk production by lactating sows. Thus, an adequate amount of dietary Arg as a quantitatively major nutrient is necessary to support maximum growth, lactation, and reproduction performance of swine. These results also have important implications for improving the nutrition and health of humans and other animals.

Feed preference of weaned pigs fed diets containing soybean meal, Brassica napus canola meal, or Brassica juncea canola meal

Brassica napus and Brassica juncea canola meal (CM) may replace soybean meal (SBM) in pig diets, but differ in fiber, glucosinolates content and profile. Preference of weaned pigs provided double-choice selections to diets containing 20% SBM, B. napus CM, or B. juncea CM was evaluated in two studies. In experiment 1, 216 pigs (9.4 ± 1.6 kg initial BW) were housed in 27 pens of 8 pigs (four gilts and four barrows). In experiment 2, 144 pigs (8.9 ± 1.1 kg) were housed in 36 pens of 4 pigs (two gilts and two barrows). Pigs were offered three dietary choices: B. napus CM with SBM as reference (B. napus CM [SBM]), B. juncea CM with SBM as reference (B. juncea CM [SBM]), and B. juncea CM with B. napus CM as reference (B. juncea CM [B. napus CM]) in a replicated 3 × 3 Latin square. Diets were formulated to provide 2.4 Mcal NE/kg and 4.5 g standardized ileal digestible Lys/Mcal NE and were balanced using canola oil and crystalline AA. Each pair of diets was offered in two self-feeders per pen as mash (experiment 1) or pellets (experiment 2) during three test-periods of 4-d, followed by a 3-d non-test period when a common diet was offered in both feeders. Feeders with different diets were rotated daily among pens during preference periods for both experiments, and feeder positions (right or left) were switched daily in experiment 2. Prior to the study and between periods, pigs were fed non-test diets containing SBM (experiment 1) or without test feedstuffs (experiment 2). Overall in both experiments, pigs preferred (P < 0.001) SBM over B. napus and B. juncea CM diets, and preferred (P < 0.001) B. napus over B. juncea CM diet. Dietary choice did not affect (P > 0.05) growth performance in both experiments, except for greater G:F (P < 0.05) for pigs fed the B. juncea CM [B. napus CM] diets than pigs fed the B. napus CM [SBM] or B. juncea CM [SBM] diets in experiment 1. In conclusion, weaned pigs preferred SBM over CM diets when given a choice, and preferred B. napus over the B. juncea diet that contained more total glucosinolates especially gluconapin. Weaned pigs fed the B. juncea CM [B. napus CM] diets in the double-choice selection did not reduce feed intake, weight gain, and G:F compared to pigs fed the B. napus CM [SBM] or B. juncea CM [SBM] diets.

Catabolism and safety of supplemental L-arginine in animals

L-arginine (Arg) is utilized via multiple pathways to synthesize protein and low-molecular-weight bioactive substances (e.g., nitric oxide, creatine, and polyamines) with enormous physiological importance. Furthermore, Arg regulates cell signaling pathways and gene expression to improve cardiovascular function, augment insulin sensitivity, enhance lean tissue mass, and reduce obesity in humans. Despite its versatile roles, the use of Arg as a dietary supplement is limited due to the lack of data to address concerns over its safety in humans. Data from animal studies are reviewed to assess arginine catabolism and the safety of long-term Arg supplementation. The arginase pathway was responsible for catabolism of 76-85 and 81-96 % Arg in extraintestinal tissues of pigs and rats, respectively. Dietary supplementation with Arg-HCl or the Arg base [315- and 630-mg Arg/(kg BW d) for 91 d] had no adverse effects on male or female pigs. Similarly, no safety issues were observed for male or female rats receiving supplementation with 1.8- and 3.6-g Arg/(kg BW d) for at least 91 d. Intravenous administration of Arg-HCl to gestating sheep at 81 and 180 mg Arg/(kg BW d) is safe for at least 82 and 40 d, respectively. Animals fed conventional diets can well tolerate large amounts of supplemental Arg [up to 630-mg Arg/(kg BW d) in pigs or 3.6-g Arg/(kg BW d) in rats] for 91 d, which are equivalent to 573-mg Arg/(kg BW d) for humans. Collectively, these results can help guide studies to determine the safety of long-term oral administration of Arg in humans.

Orally supplemented L-arginine impairs amino acid absorption depending on dose in horses

The beneficial effect of L-arginine (L-Arg) supplementation, on the physiology of several species, has generated an interest in the use of L-Arg as a nutraceutical in horses, but dosage and absorption of orally supplemented L-Arg must be inferred from other species. The study objective was to determine the effect of 2 oral L-Arg doses on plasma arginine concentrations and the effect on absorption of other amino acids in mares. In Experiment 1, mares were blocked by age and breed and were fed L-Arg supplemented (supplemented with 0.025% BW L-Arg; n=6) or control (no supplement; n=6) concentrate on a single day with blood samples taken at 0, 0.5, 1, 2, 3, 4, and 5 h relative to feeding. In Experiment 2, mares (n=6) were used in a 3×3 Latin square design with L-Arg (0.0125% of BW), urea (0.0087% of BW), and control (no supplement) fed mixed into a grain concentrate as single meal with blood samples taken at 0, 1,2, 4, 6, 8,10, and 12 h relative to feeding. In Experiment 1, L-Arg supplementation increased (P<0.05) plasma L-Arg and ornthine concentrations and decreased (P<0.05) lysine and methionine concentrations compared with the control group. At 1 h post feeding, L-Arg mares had lower (P<0.05) plasma concentrations of histidine, glutamic acid, proline, isoleucine, threonine, phenylalanine, leucine, valine, alanine, and taurine. In Experiment 2, L-Arg supplementation increased (P<0.05) arginine and ornithine concentrations compared with urea and control; there was no difference among other amino acids. These experiments indicate that L-Argis absorbed and, dependent on the dose, alters the absorption of other amino acids in mares.

Animal models in nutrition research

Current knowledge in nutrition is based largely on the use of appropriate animal models together with defined diets. Numerous examples are cited where animal models have been used to solve nutrient x nutrient interactions, to evaluate bioavailability of nutrients and nutrient precursors, and to test for nutrient tolerances and toxicities. Advantages, disadvantages, and idiosyncrasies of various animal species are discussed.

Pharmacokinetics and safety of arginine supplementation in animals

Anticipating the future use of arginine to enhance fetal and neonatal growth as well as to treat diabetes and obesity, we performed studies in pigs, rats, and sheep to determine the pharmacokinetics of orally or i.v. administered arginine and the safety of its chronic supplementation. Our results indicate that all 3 species rapidly catabolized the supplemental arginine. The elevated circulating concentrations of arginine generally returned to baseline levels within 4-5 h after administration, with the rates varying with the age and physiological status of the animals. The clearance of arginine was greater in pregnant than in nonpregnant animals, in young than in adult animals, in lean than in obese animals, and in type-1 diabetic than in nondiabetic animals. I.v. administration of arginine-HCl to pregnant ewes (at least 0.081 g arginine.kg body weight-1.d-1) did not result in any undesirable treatment-related effect. Neonatal pigs, growing-finishing pigs, pregnant pigs, and adult rats tolerated large amounts of chronic supplemental arginine (e.g. 0.62, 0.32, 0.21, and 2.14 g.kg body weight-1.d-1, respectively) administered via enteral diets without the appearance of any adverse effect. On the basis of the comparative studies and a consideration of species differences in food intake per kilogram body weight, we estimate that a 70-kg human subject should be able to tolerate long-term parenteral and enteral supplemental doses of 6 and 15 g/d arginine, respectively, in addition to a basal amount of arginine (4-6 g/d) from regular diets.

Lysine, arginine, and related amino acids: an introduction to the 6th amino acid assessment workshop

The focus of the 6th workshop is on lysine, arginine, and related amino acids. Functions, metabolic pathways, clinical uses, and upper tolerance intakes are emphasized in the articles that follow. Lysine is arguably the most deficient amino acid in the food supply of countries where poverty exists, and since the discovery of the nitric oxide synthase pathway, arginine has come into prominence clinically because of the role of nitric oxide in cardiovascular physiology and pathophysiology.

Nutritional consequences of interspecies differences in arginine and lysine metabolism

Differences in lysine and arginine requirements among various species such as omnivores (humans, pigs, rats, dogs), carnivores (cats), herbivores (rabbits, horses), ruminants (cattle), poultry, and fish, are covered in detail in this article. Although lysine is classified as an indispensable amino acid across species, the classification of arginine as either an indispensable or dispensable amino acid is more ambiguous because of differences among species in rates of de novo arginine synthesis. Because lysine is most often the limiting amino acid in the diet, its requirement has been extensively studied. By use of the ideal protein concept, the requirements of the other indispensable amino acids can be extrapolated from the lysine requirement. The successful use of this concept in pigs is compared with potential application of the ideal protein concept in humans. The current dietary arginine requirement varies widely among species, with ruminants, rabbits, and rats having relatively low requirements and carnivores, fish, and poultry having high requirements. Interspecies differences in metabolic arginine utilization and reasons for different rates of de novo arginine synthesis are reviewed in detail, as these are the primary determinants of the dietary arginine requirement. There is presently no dietary requirement for humans of any age, although this needs to be reassessed, particularly in neonates. A thorough understanding of the factors contributing to the lysine and arginine requirements in different species will be useful in our understanding of human amino acid requirements.

Excess dietary L-cysteine, but not L-cystine, is lethal for chicks but not for rats or pigs

A comparative species investigation of the relative pharmacologic effects of sulfur amino acids was conducted using young chicks, rats, and pigs. Ingestion of excess Met, Cys, or Cys-Cys supplemented at 2.5-, 5.0-, 7.5-, or 10 times the dietary requirement in a corn-soybean meal diet depressed chick growth to varying degrees. Strikingly, ingestion of excess Cys at 30 g/kg Cys (7.5-times the dietary requirement) caused a chick mortality rate of 50% after only 5 d of feeding. Growth was restored and chick mortality was reduced by supplementing diets containing 25 g/kg excess Cys with KHCO3 at 10 g/kg. Additionally, mortality was prevented by supplementing the drinking water of chicks receiving 25 g/kg supplemental Cys with H2O2 (0.05% final concentration). After young rats and pigs consumed excess Cys or Cys-Cys up to 40 g/kg for 14 d, weight gain was severely depressed, but we observed no mortality. An excess of dietary Cys-Cys>or=48 g/kg caused some mortality in rats. Pigs exhibited rapid recovery from growth-depressing excesses of Cys or Cys-Cys. These results lend credence to the acute toxic effects associated with the ingestion of excess sulfur amino acids and highlight the potential for excess dietary cyst(e)ine to be more pernicious than Met in certain species.

Comparative species utilization and toxicity of sulfur amino acids

Animal studies have shown that several methionine (Met) and cysteine (Cys) analogs or precursors have L-Met- and L-Cys-sparing activity. Relative oral bioavailability (RBV) values, with the L-isomer of Met and Cys set at 100% (isosulfurous basis), are near 100% for D-Met for animals but only about 30% for humans. Both the OH and keto analogs of Met have high RBV-sparing values, as does N-acetyl-L-Met (the D-isomer of acetylated Met has no bioactivity). L-Homocysteine has an RBV value of about 65% for Met sparing in rats and chicks, but D-homocysteine has little if any Met-sparing activity. S-Methyl-L-Met can partially spare Met, but only when fed under dietary conditions of choline/betaine deficiency. Relative to L-Cys, high RBV values exist for L-cystine, N-acetyl-L-Cys, L-homocysteine, L-Met, and glutathione, but D-cystine, the keto analog of Cys, L-cysteic acid, and taurine have no Cys-sparing activity. l-2-Oxothiazolidine-4-carboxylate has an RBV value of 75%, D-homocysteine 70%, and DL-lanthionine 35% as Cys precursors. Under dietary conditions of Cys deficiency and very low inorganic sulfate (SO4) ingestion, dietary SO4 supplementation has been shown to reduce the Cys requirement of several animal species as well as humans. Excessive ingestion of Met, Cys, or cystine has also been studied extensively in experimental animals, and these sulfur amino acids (SAA) are well established as being among the most toxic of all amino acids that have been studied. Even though Cys and its oxidized product (cystine) are equally efficacious at levels at or below their dietary requirements for maximal growth, Cys is far more toxic than cystine when administered orally in the pharmacologic dosing range. Isosulfurous (excess) levels of cystine, N-acetyl-L-Cys, or glutathione are far less growth depressing than L-Cys when 6 to 10 times the minimally required level of these SAA compounds are fed to chicks.

Animal models of human amino acid responses

The principal differences between experimental animals and humans with regard to amino acid responses are 1) growing animals partition most of their amino acid intake to protein accretion, whereas growing children partition most of their intake to maintenance; 2) invasive assessment procedures are common in animals but very limited in humans; and 3) humans can describe how they feel in response to amino acid levels or balances, whereas animals cannot. New (pharmacologic) uses of amino acids have been and are being discovered (e.g., cysteine, arginine, leucine, glutamine), and this makes it imperative that tolerance limits be established. Work with pigs suggests that excessive intake of methionine and tryptophan present the biggest problems, whereas excessive intake of threonine, glutamate, and the branched-chain amino acids seems to be well tolerated.

Specific dietary selection for tryptophan by the piglet1

The aim of the present study was to investigate whether pigs prefer diets varying in Trp content and whether these preferences change with time. To that end, a feeding trial was carried out over a 6-wk period. Piglets (equal proportion of males and females) with an initial BW of 8.20 +/- 0.90 kg were randomly subdivided into four groups of 12 pigs each. Two reference groups were fed (as-fed basis) either 0.11% Trp (Trp-deficient) or 0.20% Trp (Trp-adequate) diets. Two other groups had a choice of two diets containing either 0.11 or 0.16% Trp (Trp-choice 1), or 0.11 or 0.20% Trp (Trp-choice 2). Average daily feed intake reached 335 and 366 g in pigs fed Trp-deficient and Trp-choice 1 diets, respectively. For Trp-choice 2 and Trp-adequate diets, a higher (P < 0.05) feed intake of 589 and 645 g/d, respectively, was observed. Piglets on Trp-choice 1 and Trp-choice 2, respectively, selected 87 and 93% of the higher Trp diet. Resulting Trp contents of total diets were 0.15 and 0.19% (as-fed basis) in Trp-choice 1 and Trp-choice 2, respectively. In wk 1, pigs on Trp-choice 2 chose lower proportions of the Trp-deficient feed (31% of total diet) than did pigs on Trp-choice 1 (44%), but at the end of the experiment, pigs of both groups almost exclusively chose the feed with the higher Trp content (96 and 98% for Trp-choice 1 and 2). Pigs on Trp-choice 1 had an ADG of 218 g, which was only slightly above the ADG of Trp-deficient pigs (198 g). Pigs on Trp-choice 2 and Trp-adequate diets had ADG of 404 and 458 g, respectively, which were higher (P < 0.05) than those observed for Trp-deficient and Trp-choice 1 groups. Plasma Trp concentrations in Trp-choice 2 and Trp-adequate groups (9.21 and 9.01 micromol/mL, respectively) were higher (P < 0.05) than in Trp-deficient and Trp-choice 1 groups (5.88 and 4.96 micromol/mL, respectively). Conversely, the sum of essential AA showed a higher (P < 0.05) concentration in plasma from pigs on the Trp-deficient and Trp-choice 1 diets than in plasma from pigs on Trp-choice 2 and Trp-adequate diets. Nutritional depletion of Trp influences the food selection behavior of piglets. Results of growth performance and the dietary preferences suggest that piglets are able to detect Trp-deficiency-induced metabolic changes and respond with an aversion against the Trp-deficient diet.

Dietary supplements of mixtures of indispensable amino acids lacking threonine, phenylalanine or histidine increase the activity of hepatic threonine dehydrogenase, phenylalanine hydroxylase or histidase, respectively, and prevent growth depressions in chicks caused by dietary excesses of threonine, phenylalanine, or histidine*

Experiments were carried out to determine whether the addition of a mixture of indispensable amino acids (IAA) lacking in threonine, phenylalanine or histidine, respectively, to a nutritionally complete diet would increase the hepatic activities of the rate-limiting enzymes for catabolism of threonine, phenylalanine or histidine and prevent the adverse effects of the amino acid on growth when the dietary level of the amino acid is excessive. Week old Leghorn chicks were fed semi-purified diets containing 19% crude protein to which were added no IAA supplement or 10% crude protein from an IAA mix and 5 graded levels of either L-threonine, L-phenylalanine or L-histidine in a 2 x 5 factorial arrangement of treatments. Each amino acid was investigated in a separate experiment involving four replicate pens (seven chicks each) per diet. Weight gains and feed consumptions were determined on the fourteenth day of each experiment. The groups receiving no excess, and 1.0% or 2.0% excesses of amino acids were sampled on the fifteenth day for enzyme activities and plasma amino acid concentrations. Weight gain and/or feed consumption were lower, and plasma concentrations of threonine, phenylalanine and histidine were higher, in chicks receiving 1.5 to 2.0% dietary additions of threonine, phenylalanine, and histidine, respectively, than in chicks that did not receive these amino acids. Chicks that received the amino acids in diets that also contained the IAA supplement had better growth and feed consumption, lower plasma concentrations of threonine, phenylalanine or histidine, higher plasma concentrations of other indispensable amino acids, and higher activities of threonine dehydrogenase, phenylalanine hydroxylase, and histidase than chicks receiving excess amino acids in the absence of IAA supplements. We conclude that the dietary level of protein, not the dietary level of individual amino acids, is the primary determinant of the activity of amino acid degrading enzymes in liver. The increased activity of these enzymes may be the mechanism by which dietary protein alleviates the adverse effects of excessive levels of individual amino acids.

Excess dietary methionine markedly increases the vitamin B-6 requirement of young chicks

A soy-protein isolate diet that contained essentially no bioavailable vitamin B-6 was used to establish the quantitative effect of excess dietary methionine on the vitamin B-6 requirement of young chicks. When made adequate in vitamin B-6, chicks fed the basal diet required 2 g/kg supplemental DL-methionine to achieve maximal growth, and 10 g/kg additional DL-methionine (total = 12 g/kg) was found to be a tolerable excess level that would not depress voluntary food intake or growth rate. When chicks were fed seven graded doses of supplemental pyridoxine (PN) in diets that contained either adequate (2 g/kg) or excess (12 g/kg) methionine, the vitamin B-6 requirement for maximal growth was found to increase (P: < 0.01) from 0.73 to 1.05 mg/kg, a 44% increase, when 10 g/kg excess methionine was present in the diet. Indeed, this level of excess dietary methionine depressed (P: < 0.01) growth at all PN dose levels < or =1 mg/kg, but not at PN doses of 1.2 or 1.4 mg/kg. Because dietary intakes of both vitamin B-6 and methionine can affect plasma homocysteine levels, dietary methionine (and protein) intake should be considered important factors in setting safe and adequate requirement levels for vitamin B-6.

D-allothreonine has no growth promoting efficacy for chicks

One hundred and sixteen crossbred male chicks were used in two battery trials to establish the biological efficacy and toxicity of D-allothreonine (D-allo-Thr) relative to L-Thr. In the efficacy trial, graded doses of D-allo-Thr or L-Thr were added to a Thr-deficient (0.24% L-Thr) chemically defined diet and fed to chicks during the period 10 to 21 d posthatching. Addition of 0, 0.09, and 0.18% L-Thr produced marked linear (P < 0.01) growth and feed efficiency responses, but addition of 0.18 or 0.36% D-allo-Thr did not elicit a response in either weight gain or feed efficiency. In the toxicity trial, 2% D-allo-Thr or 2% L-Thr were added to a conventional 23% CP corn-soybean meal starter diet. During an 11-d feeding period, neither weight gain nor voluntary feed intake were affected (P > 0.10) by 2% additions of either compound. This experiment demonstrates that chicks cannot metabolize D-allo-Thr to L-Thr and that neither L-Thr nor D-allo-Thr are growth depressing when provided in a large surfeit.

Neurotoxicology and amino acid intake during development: the case of threonine

The development of the central nervous system is highly dependent on an adequate supply of nutrients. In particular, protein and amino acid availability is of major concern during gestation and in early postnatal life. Numerous data have been published on some amino acids directly involved in brain functions as neurotransmitters or indirectly as precursors of neurotransmitters, but scant information is available on the possible consequences of hyperthreoninemia, a phenomenon repeatedly noted in clinical reports. The results of neurochemical and behavioral studies in the developing rat suggest that despite numerous possible effects of threonine on brain constituents, moderate hyperthreoninemia does not impair markedly the development of the central nervous system.

Modification of the effects of blood on amino acid metabolism by intravenous isoleucine

The absence of isoleucine in the hemoglobin molecule has been suggested to contribute to increased urea production after a blood meal. To unravel the underlying mechanism, the effects of isoleucine infusion after blood ingestion in the healthy pig were studied. The isoleucine dose was chosen to induce an arterial isoleucine increase comparable to those observed for leucine or valine after blood ingestion. For the experiments, 10 female overnight-fasted pigs (20-25 kg) received 250 mL bovine erythrocytes intragastrically 1 week after catheter implantation for measuring hepatic, splanchnic, portal-drained viscera, and hindquarter fluxes of amino acids, urea, and ammonia. After the administration of erythrocytes, isoleucine or saline was administered i.v. for 6 hours. The data obtained show that the increase in arterial levels of urea and almost all amino acids was significantly greater in the control group (P less than 0.001) than in the isoleucine group. The net efflux of nearly all amino acids by the portal-drained viscera increased significantly less (P less than 0.001) in the isoleucine group. The liver uptake of amino acids increased after the blood meal, but the difference was not significant except for glutamine (P less than 0.001). Hindquarter amino acid net influx increased marginally. Splanchnic urea production increased more in the control group than in the isoleucine group (P less than 0.05). The data strongly suggest that i.v. administration of isoleucine enhanced the biological value of a blood meal, possibly by promoting amino acid retention in the portal drained viscera.